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Cellular senescence is a stable form of cell cycle arrest with roles in many 
pathophysiological processes including development, tissue repair, cancer and 
aging. Senescence does not represent a single entity but rather a heterogeneous 
phenotype that depends on the trigger and cell type of origin. Such 
heterogeneous features include alterations to chromatin structure and epigenetic 
states. New technologies are beginning to unravel the distinct mechanisms 
regulating chromatin structure during senescence. Here we describe the multiple 
levels of chromatin organization associated with senescence: global and focal, 









More than fifty years ago Hayflick and Moorhead formally described cellular 
senescence as the stable proliferative arrest observed in primary human 
fibroblasts when cultured in vitro for extended periods (Hayflick and Moorhead 
1961; Hayflick 1965). Today we know that the phenomenon they observed 
represents one type of senescence, replicative senescence, which is triggered 
because dividing cells, in the absence of telomerase, progressively shorten their 
telomeres. Critically short telomeres malfunction and trigger senescence through 
the DNA damage response (DDR) (Shay and Wright 2000; Zglinicki et al. 2005). 
Similar senescence phenotypes can be triggered by various pathophysiological 
stimuli including stress from cytotoxic/ genotoxic drugs, modulation of chromatin 
states (Ogryzko et al. 1996; Prieur et al. 2011) high levels of reactive-oxygen 
species (ROS) (Chen et al. 1995; Lee et al. 1999; Macip et al. 2002) and hyper-
activation of oncogenes such as RAS, causing oncogene-induced senescence (OIS) 
(Serrano et al. 1997; Gorgoulis and Halazonetis 2010). Although originally defined 
in cell culture models, senescence has also been identified in vivo. For example, 
senescence plays a functional role in tissue homeostasis and wound healing 
4 
 
(Wiemann et al. 2002; Krizhanovsky et al. 2008; Jun and Lau 2010), embryonic 
development (Storer et al. 2013; Chuprin et al. 2013; Muñoz-Espín et al. 2013) 
aging and age-related disorders including cancer, atherosclerosis and 
osteoarthritis (Minamino et al. 2002; Price et al. 2002; Muñoz-Espín and Serrano 
2014; Pérez-Mancera et al. 2014). 
 
Since originally suggested in Hayflick’s seminal description (Hayflick and 
Moorhead 1961), evidence linking senescence and aging has been accumulating 
(note here that we use the term ‘senescence’ as the cell phenotype described 
above, distinct from ‘aging’, a term we use in reference to organismal 
aging)(Figure 1). Earlier studies showed an inverse correlation between 
proliferative capacity of cells in culture and donor age, although this appears to 
be controversial (Cristofalo et al. 2004). Senescent cells have been shown to 
accumulate in some (but not all) tissues of aging mice and primates (Herbig et al. 
2006; Jeyapalan et al. 2007; Wang et al. 2009). In particular, age-dependent 
accumulation of senescent cells in tissue stem and progenitor cell compartments 
suggests that senescence could contribute to aging by limiting the regenerative 
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capacity of the tissue (reviewed in Sharpless and DePinho 2007). Consecutive 
studies in BubR1 mice (Baker et al. 2008; Baker et al. 2011), a progeroid model 
that has high levels of constitutive DNA damage due to a hypomorphic mutation 
in Bub1b, and more recently in naturally aged mice (Baker et al. 2016), suggest 
that an accumulation of senescent cells has a detrimental effect on longevity 
(Kapanidou et al. 2015). Here, genetic inactivation of senescence or the induction 
of apoptosis in senescent cells (specifically p16-expressing cells) significantly 
attenuates the progression of age-related disorders (Baker et al. 2008; Baker et al. 
2011, Baker et al. 2016). Thus understanding the diverse phenotype referred to as 
‘senescence’, and its functional roles in vivo, would likely provide insights into the 
various aspects of organismal aging. 
 
Senescence involves various effector mechanisms including the DDR, alterations 
to cellular metabolism and protein secretion as part of the senescence-associated 
secretory phenotype. These senescence effectors are extensively reviewed 
elsewhere (Salama et al. 2014; Muñoz-Espín and Serrano 2014; Pérez-Mancera et 
al. 2014). In this Review, we focus on the dramatic higher order chromatin 
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structural changes observed during senescence, including a rearrangement of 
heterochromatin, and the effectors responsible. First we discuss general aspects of 
heterochromatin assembly and what is known about heterochromatin in 
senescent and aging-associated cells. We comment on the potential implications 
of chromatin structure in senescent cells on gene regulation and age-related 
disease initiation, particularly cancer. Finally, we describe higher order chromatin 
structure in senescent cells and discuss how recent research suggests that distinct 




Chromatin constitutes one of the most complex macromolecular entities in the 
cell, harbouring genomic DNA as well as thousands of directly or indirectly 
associating proteins and RNA molecules working in concert to mediate gene 
transcription or repression. Fitting human DNA within the relatively tiny 
boundaries of the nucleus requires several magnitudes of coiling and compaction. 
Around 146 base pairs of DNA are coiled around a nucleosome; a fundamental 
7 
 
protein complex composed of an octamer of paired histone proteins - H2A, H2B, 
H3 and H4. Unstructured N- and C-terminal histone tails protrude from the 
nucleosome complex susceptible to decoration with a variety of post-translational 
modifications (PTMs, often called histone marks). These modifications can have 
profound effects on chromatin structure and can therefore demarcate active and 
repressed domains (Luger et al. 2012). 
 
The packaging of chromatin is highly dynamic; it can be loosely packaged 
euchromatin and thus allow access to the transcriptional machinery, or tightly 
packaged heterochromatin thereby limiting access. Heterochromatin can be 
further classified into two subtypes - constitutive heterochromatin is condensed in 
all differentiated cell types throughout the cell cycle. Facultative heterochromatin, 
the second subtype, is found at developmentally regulated loci and therefore 
varies between cell types and in response to cellular signals. 
 
Emil Heitz (1928) originally defined heterochromatin based on the dense pattern 
of DNA staining detectable via microscopy of cells in interphase. Particularly, 
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constitutive heterochromatin can be observed at the nuclear periphery and in the 
telomeric and pericentromeric regions of chromosomes. Since then various 
biochemical markers of heterochromatin and/or gene repression have been 
characterized: for example DNA methylation (specifically 5-methylcytosine in CpG 
dinucleotides), lysine hypoacetylation of histones H3 and H4, methylation of 
histone H3 on lysine 9 (H3K9me3) (enriched in constitutive heterochromatin), and 
H3K27me3 (enriched in facultative heterochromatin) (Grewal and Jia 2007; Moazet 
et al. 2001; Trojer and Reinberg 2007). Consistently, condensed regions tend to be 
more resistant to DNase I digestion (Sperling et al. 1985) indicating that 




The predominant model of heterochromatin formation involves a ‘spreading’ of 
heterochromatin across the linear genome to proximal regions (Figure 2 A). 
Position-effect variegation (PEV) was first characterized by Muller (Muller et al. 
1935) in drosophila models where a euchromatic section of chromatin can be 
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silenced if artificially juxtaposed adjacent to a segment of heterochromatin via 
chromosome rearrangement. This process of silencing appears to begin early on 
during embryogenesis (Karpen 1994; Lu et al. 1996; Ebert et al. 2006). Similarly, 
during initiation of random X-chromosome inactivation in the embryonic cells of 
female mammals the establishment of H3K27me3 and the recruitment of 
polycomb group (PcG) binding proteins are early events which closely parallel 
with Xist RNA accumulation. Such marks are thought to allow propagation of the 
inactive state along the chromosome (Heard et al. 2001; Mermoud et al. 2002; 
Silva et al. 2003; Plath et al. 2003). In addition, the spreading of repressive histone 
marks has been shown at a genome-wide level. ChIP-seq analyses revealed that 
sparse blocks of repressive H3K9me3 and H3K27me3 observed in human 
embryonic stem cells (ESCs) significantly expand as cells differentiate (Mikkelsen 
et al. 2007; Hawkins et al. 2010). 
 
ESCs are unique in their plasticity, pluripotency and ability to self renew. 
Consistently, chromatin in ESCs is globally de-condensed and enriched for 
euchromatic modifications (Arney and Fisher 2004; rer and Misteli 2006) whilst 
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heterochromatin is dispersed and poorly defined (Ahmed et al. 2010). The 
openness of chromatin is correlated with high DNAse I accessibility and hyper-
transcription of coding genes as well as repetitive elements – e.g. satellite repeat 
elements (Meshorer et al. 2006; Efroni et al. 2008; Fisher and Fisher 2011). As cells 
differentiate and a specific transcriptional program is selected there is an 
accumulation of heterochromatin and silencing histone modifications (Meshorer 
et al. 2006; Meshorer and Misteli 2006). 
 
Of note, beside unicellular organisms, such as yeast (Grewal and Jia 2007), the 
experimental models to describe heterochromatin spreading primarily involve 
embryonic development, which often accompanies morphological alterations to 
chromatin (e.g. Xi formation and ESC differentiation, discussed above). These 
studies suggest some correlation between heterochromatin spreading and DNA 
‘compactness', at least during early developmental stages, but a causative role for 
‘quantity’ of repressive histone marks in high-order heterochromatin formation is 





Chromatin, Senescence and Aging 
 
Alterations to epigenetic and chromatin states during senescence have long been 
observed. Earlier studies showed that global DNA methylation is reduced in 
replicatively senescent, but not in immortalized, fibroblasts from rodents and 
humans (Wilson and Jones 1983; Gray et al. 1991). In addition, treatment of 
human fibroblasts with chromatin modifying reagents that can counter 
heterochromatin formation, such as inhibitors of histone deacetylases or DNA 
methylation, reduces their proliferative lifespan (Gray et al. 1991; Ogryzko et al. 
1996). These studies have provoked the “loss of heterochromatin” model of 
senescence, which proposes that heterochromatic domains established during 
early development are broken down resulting in derepression of silenced genes 
and aberrant gene expression, which may contribute to the senescence and/or 
aging phenotype (Villeponteau 1997). Interestingly, it has been shown that hypo-
methylation at some pericentric satellite regions (constitutive heterochromatin) 
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during replicative senescence is correlated with de-repression of transcription at 
these regions (Suzuki et al. 2002; Enukashvily et al. 2007; Cruickshanks et al. 2013). 
 
More recent studies, however, suggest that the loss of heterochromatin model is 
too simplistic (Schellenberg et al. 2011; Cruickshanks et al. 2013). Using whole 
genome single-nucleotide bisulfite-sequencing, Cruickshanks and colleagues 
illustrated that, in human fibroblasts approaching replicative senescence, there is 
simultaneous global DNA hypo-methylation and focal hyper-methylation 
(Cruickshanks et al. 2013). DNA hypo-methylation is enriched at gene-poor, late 
replicating sequences, and in nuclear lamina-associated domains (LADs), which are 
all typically associated with heterochromatic histone marks. On the other hand, 
focal hyper-methylation is enriched at CpG islands, localized at gene promoters, 
where methylation usually results in repression of the gene. It is conceivable that 
the global loss of DNA methylation (and de-repression of some satellite 
transcripts mentioned above) might contribute to subsequent genomic instability, 
whereas gain of DNA methylation at CpG islands might affect cell phenotype by 
altering the gene expression profile.. Although caution is required when directly 
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inferring pathology of organismal aging from a replicative senescence phenotype 
in vitro (Cristofalo et al. 2004), given that these methylation changes are 
reminiscent of cancer the authors speculate that senescence-associated DNA 
methylation alterations might promote cancer as an age-related disorder in vivo 
(Cruickshanks et al. 2013). Indeed, such genome-wide hypomethylation and focal 
hypermethylation of CpG islands has also been noted in the context of aging 
(Reviewed in Zampieri et al. 2015). 
 
Levels of heterochromatic histone marks have also been reported to alter during 
senescence, but the directionality of the change appears to be dependent on the 
type of senescence. For example, it was reported that the total level of H3K9me3 
in OIS cells, but not replicatively senescent cells, is increased when compared to 
proliferative control cells in culture (Di Micco et al. 2011). Comparatively, 
H3K9me3, the HP1 proteins and H3K27me3 were all found to be reduced in 
cultured fibroblasts derived from patients with the premature aging disorder 
Hutchinson-Gilford progeria syndrome (HGPS), caused by a point mutation (1824 
C –>T) in the LMNA gene, as well as in fibroblasts from old individuals (Scaffidi 
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and Misteli 2006; Shumaker et al. 2006; Dechat et al. 2008). Of note, this 
reduction of heterochromatic marks appears to be particularly relevant after 
substantial passage in culture, thus it is not clear whether the reduction of these 
repressive marks are primary changes associated with individual aging or a part of 
a  ‘senescence’ phenotype caused by replicative and oxidative stress. Indeed, 
HGPS cells have been shown to be more susceptible to premature senescence 
than unaffected control cells in culture (Liu and Zhou 2008). Interestingly, a recent 
study showed that the H3K9me3 level in HGPS cells is often higher at an early 
passage compared to cells isolated from healthy individuals (Liu et al. 2013). 
Similar results were obtained in embryonic fibroblasts from progeroid mice, which 
lack the prelamin-A processing metalloprotease, Zmpste24 (Liu et al. 2013). The 
authors suggest that the loss of H3K9me3 in HGPS cells observed in earlier 
studies might be due to the secondary effect of extensive replicative stress in 
culture (Liu et al. 2013). Whether or not such a rapid reduction of 
heterochromatin at late passage is unique to cells isolated from HGPS patients or 
older individuals is an interesting question, particularly considering that the global 
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alteration of heterochromatic marks appears to be non-uniform within various 
types of senescence. Nevertheless, the data in this study (Liu et al. 2013) do not 
exclude the possibility that similar epigenetic alterations observed in late passage 
HGPS in culture might occur in certain types of cells (e.g. tissue stem/ progenitor 
cells) in vivo, contributing to deterioration of the tissue microenvironment during 
the (premature) aging process.  
 
Thus the enrichment of heterochromatin modifications does indeed change 
during senescence but directionality is difficult to dissect due to the vast 
heterogeneity of the phenotype. In addition, as shown in the case of DNA 
methylation, it will be critical to consider that individual epigenetic marks may be 
‘redistributed’ at specific loci during senescence in addition to changing at a 
global level. Moreover and as mentioned in previous sections of this review, the 
link between the ‘quantity’ of heterochromatic histone marks and higher-order 
chromatin structure, remains unclear. A number of recent studies using new 
technologies have begun to study alterations to higher-order chromatin structure 
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in senescent cells in unprecedented detail – these will be discussed in the 
following sections. 
 
Senescence-associated heterochromatic foci 
 
Senescent cells exhibit dramatic alterations to higher-order chromatin structure. 
Notably, in some senescent cells there is the formation of senescence associated 
heterochromatic foci (SAHFs) (Narita et al. 2003; Zhang et al. 2005), DAPI-dense 
foci inside the nucleus readily visible by fluorescence microscopy. It has been 
suggested that these structures contribute to the irreversibility of the senescence 
phenotype by packaging proliferative genes, such as those silenced by the 
retinoblastoma (RB) tumor suppressor protein, into repressed heterochromatic 
domains (Narita et al. 2003; Beausejour 2003; Chicas et al. 2010; Sadaie et al. 
2013).  
 
Diverse effectors of SAHF structure have been identified (Figure 2 B) (Adams 2007; 
Salama et al. 2014). For example, knockdown of RB and its upstream activator p16 
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inhibit SAHF formation (Narita et al. 2003). Studies in the Adam’s laboratory 
identified other key modulators of SAHF including histone chaperone proteins 
Histone Repressor A (HIRA) and Anti-silencing Factor 1a (ASF1a) (Zhang et al. 
2005; Zhang et al. 2007). These are important for euchromatic deposition of the 
histone variant H3.3 during senescence (Corpet et al. 2013), where histone H3.3 
can be actively demethylated at lysine 4 or proteolytically cleaved (Chicas et al. 
2012; Duarte et al. 2014). Promyelocytic leukemia (PML) nuclear bodies (NBs), 
which become prominent in number and size during senescence (Pearson et al. 
2000; Ferbeyre et al. 2000; Bischof et al. 2002), are thought to provide a 
convergence point for multiple factors and complexes prior to SAHF formation 
(e.g. Rb-E2F complexes, HP1, the HIRA/ASF1a complex, histone H3.3 and the RB 
phosphatase) PP1α) (Zhang et al. 2005; Vernier et al. 2011; Corpet et al. 2013). 
The relocalization of HIRA to PML bodies was reported to be driven by repression 
of canonical Wnt signaling, facilitating SAHF formation (Ye et al. 2007). Another 
recent study from the Zhang laboratory identified SPOP, an E3 ubiquitin ligase 
adaptor, as a potential uprestream regulator of SAHF formation: upregulation of 
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SPOP during senescence induces degradation of the SENP7 deSUMOylase, 
resulting in HP1α sumoylation. The authors suggest that increased HP1α 
sumoylation facilitates HP1α deposition into SAHFs, whereas it only weakly 
promotes its relocation to PML bodies (Zhu et al. 2015).  High-mobility group A 
(HMGA) proteins are chromatin architectural proteins that bind the minor-groove 
of AT-rich DNA, especially in DNA linker-regions between nucleosomes (Reeves 
2001). Upregulation of HMGA proteins and downregulation of their competitor 
for linker DNA, Histone-H1, were implicated in SAHF formation (Narita et al. 2006; 
Funayama et al. 2006). HMGA proteins in particular are essential structural 
components of SAHFs.  
 
SAHFs were named as such because they are enriched for many markers of 
heterochromatin including HP1 proteins, the facultative heterochromatin histone 
variant macroH2A, H3K9me3 and H3K27me3, whilst they exclude euchromatic 
markers such as H3K4me3 and H3K36me3 (Narita et al. 2003; Zhang et al. 2005). 
Interestingly, it has been shown that individual SAHFs are composed of single 
chromosomes (Funayama et al. 2006; Zhang et al. 2007). Furthermore, previous 
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studies in our lab have shown that SAHFs are made up of multiple forms of 
chromatin arranged into concentric layers. Each consists of a core enriched for 
constitutive heterochromatin marked by H3K9me3 encircled by facultative 
heterochromatin enriched for H3K27me3. Euchromatic histone marks lie outside 
of the SAHF structure in DAPI-poor regions that probably represent 
transcriptionally active space (Chandra et al. 2012). 
 
Despite the dynamic structural alteration of chromatin (i.e. SAHF formation), it was 
shown that the ‘chromosome-wide’ profiles of two representative repressive 
marks, H3K9me3 and H3K27me3, as determined by ChIP-seq, change only 
moderately (with some local enrichment of H3K27me3 in gene-centric analyses) 
upon the induction of OIS in human fibroblasts even though the total level of 
chromatin bound HP1, which docks at H3K9me3, is substantially increased 
(Chandra et al. 2012; Salama et al. 2014). These data suggest that SAHF are not 
generated by a substantial re-distribution, or ‘spreading’, of histone modifications 
across the genome, but rather by a spatial rearrangement of pre-existing 
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heterochromatin involving a clustering of regions which share specific histone 
modifications (Chandra et al. 2012; Chandra and Narita 2013). 
 
How can such a drastic mobilization of heterochromatin be achieved to form 
SAHFs? There is now a wealth of literature illustrating senescence-associated 
alteration to the nuclear lamina, major components of which include A-type and 
B–type Lamins, which forms a scaffold underneath the inner nuclear membrane. 
Lamin B1 in particular is down-regulated during senescence (Shimi et al. 2011; 
Freund et al. 2012; Dreesen et al. 2013; Shah et al. 2013; Sadaie et al. 2013) 
through diverse mechanisms that involve transcriptional and/or post-translational 
regulation, the latter including the macromolecule degradation machinery, 
autophagy (Ivanov et al. 2013; Lenain et al. 2015; Dou et al. 2015). The nuclear 
lamina has been implicated in the nuclear positioning of chromatin and 
transcriptional regulation. Genome-wide mapping of Lamin B1 identified 
(sub)megabase-sized, well-defined chromatin domains (LADs), which are enriched 
for repressive marks (Guelen et al. 2008). Consistent with the primarily perinuclear 
localization of H3K9me3 in normal human fibroblasts, ChIP-seq analyses suggest 
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that H3K9me3-enriched chromatin domains are typically associated with the 
middle of LADs. Interestingly, Lamin B1 is reduced mostly from the central, 
H3K9me3-enriched, portion of LADs during senescence (Sadaie et al. 2013). These 
data suggest that the preferential loss of Lamin B1 from H3K9me3 enriched 
regions facilitates the spatial reorganization of constitutive heterochromatin into 
SAHFs, although enforced depletion of Lamin B1 is not sufficient for SAHF 
formation (Sadaie et al. 2013). Interestingly, it has been shown that, upon 
differentiation of rod cells in the eyes of nocturnal mammals, a co-absence of LBR 
(Lamin B1 receptor), which can bind HP1 (Ye et al. 1996, Ye et al. 1997), and lamin 
A/C facilitates the internalisation of constitutive heterochromatin (Solovei et al. 
2009; Solovei et al. 2013). These data may suggest the existence of an 
evolutionarily conserved mechanism for spatial regulation of heterochromatin. 
 
Although the correlation between histone marks and chromatin layering in SAHFs 
is strong, we have previously shown that depletion of H3K9me3 or H3K27me3, by 
ectopic expression of the histone demethylase JMJD2D or by RNAi depletion of 
the essential component in the histone methyltransferase complex SUZ12, 
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respectively, does not affect SAHF formation, at least at a morphological level 
(Chandra et al. 2012). Moreover, others have shown that marked depletion of 
chromatin bound HP1 proteins by overexpression of a dominant-negative HP1β 
does not cause a defect in SAHF formation (Zhang et al. 2007), suggesting that 
the non-stoichiometric increase of these proteins when compared to their binding 
site is not responsible for SAHF structure. Therefore, although correlated with the 
layers of SAHF, these abundant markers of heterochromatin are not required for 
SAHF formation. 
 
Such observations were perhaps surprising. They are in stark contrast to the 
predominant model of heterochromatin formation observed during embryonic 
development, which involves the spreading of heterochromatic marks to proximal 
regions. It appears that distinct regulatory mechanisms are employed in senescent 
cells when compared to differentiating cells at early embryonic stages: refolding 
of higher-order chromatin structure above the level of nucleosome modification 
versus spreading of heterochromatin respectively (Figure 2 A), although these may 




Senescence-associated distension of satellites 
 
It was recently shown by Swanson and colleagues that normally compacted α-
Satellite and Sat-II DNA is distended early during the senescence program, an 
observation they called Senescence-associated distension of satellites (SADS) 
(Swanson et al. 2013). Whilst SAHFs occur only in some forms of senescence 
(Narita et al. 2003; Kosar et al. 2011) and are rarely observed in vivo (Lazzerini 
Denchi et al. 2005), the authors observed the presence of SADS in many 
senescent cell types including in OIS and replicative senescence as well as in 
tissue sections of benign pancreatic intraepithelial neoplasia (PIN). SADS were also 
present in HGPS cells, which do not exhibit SAHF (Swanson et al. 2013). Moreover, 
they showed that the distribution of H3K9/27me3 across α-Satellite DNA does not 
change during senescence – further illustrating higher-order chromatin structural 




Evidence for an alteration to nucleosome density during replicative senescence 
was provided in a study carried out by the lab of John Sevidy (De Cecco et al. 
2013). Researchers used a biochemical approach: formaldehyde assisted isolation 
of regulatory elements (FAIRE-Seq), a method for mapping the distribution of 
nucleosome-depleted chromatin in comparison to nucleosome dense chromatin 
irrespective of histone modification (Giresi et al. 2007). They observed a general 
‘smoothening’ of the genome architecture such that regions that are usually 
heavily heterochromatinized with respect to nucleosome positioning, including 
pericentromeric constitutive heterochromatin and repeat elements, became 
relatively more open, whilst open regions, with the exception of some specific 
genes, become relatively more closed (De Cecco et al. 2013). Particularly, and 
consistent with the formation of SADS, it was shown that the transcription of 
satellite DNA as well as transposable elements is increased (De Cecco et al. 2013). 
This is reminiscent of DNA methylation alterations during replicative senescence 
as described earlier: the global reduction of methylation, including pericentric 
heterochromatic regions, and focal increase of DNA methylation at CpG islands, 
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which are generally open (Cruickshanks et al. 2013). The DNA methylation profile 
of OIS cells has not yet been determined and the relationship between DNA 
methylation, heterochromatic histone marks, and nucleosome position/density in 
this context remains to be elucidated. 
 
With all these data in mind, it would also be tempting to hypothesize that during 
senescence there is a ‘modular’ process of structural rearrangement – an 
unwinding of chromatin and a de-condensation of canonical heterochromatin, its 
spatial reorganization, and a refolding of chromatin to form the layered structure 
of SAHF (Figure 3).  
 
The genome wide chromatin interactome 
 
Historically, the study of higher-order chromatin structure genome wide has been 
difficult as many high-throughput sequencing methods such as chromatin 
immunoprecipitation and FAIRE-Seq provide one-dimensional information about 
the genome. More recently, methods based on high-throughput chromatin 
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conformation capture (3C) have allowed for the study of three-dimensional 
structure genome wide (Lieberman-Aiden et al. 2009; Belton et al. 2012). This 
technology provided structural validation to chromosome territories by defining 
sub-chromosomal compartments; type A (‘open’) and B (‘closed’) compartments 
(Lieberman-Aiden et al. 2009), and more recently identified  smaller mega-base 
pair sized self-interacting chromatin blocks, topologically associated domains 
(TADs) (Dixon et al. 2012; Nora et al. 2012). Many TADs can be considered as 
discrete regulatory units, where a TAD may be largely heterochromatic or 
euchromatic as indicated by biochemical markers (Le Dily et al. 2014). 
Interestingly, TAD structure is conserved as ES cells differentiate into fibroblasts 
demonstrating that heterochromatin spreading occurs within the framework of 
TADs and that higher-order chromatin structure is maintained (Nora et al. 2012), 
even though heterochromatin at a nucleosome level changes dramatically 
(Mikkelsen et al. 2007; Hawkins et al. 2010). Moreover, depletion of 




The independent relationship between TADs and repressive histone marks is 
reminiscent of the relationship between SAHF formation and histone marks, which 
are closely correlated with the layered structure of SAHF but are not required for 
their formation. Are TADs a structural unit of SAHF? Recently, Chandra and 
colleagues (Chandra et al. 2015) employed Hi-C to understand alterations to 
higher-order chromatin structure during OIS. Interestingly, they observed a 
reduction of local connectivity in TADs that are associated with heterochromatic 
features, including H3K9me3 enrichment, LADs, GC-poor (AT-rich) isochores, and 
late replication timing. Thus, TADs, which are highly conserved structural units 
during differentiation and across multiples species (Dixon et al. 2012; Nora et al. 
2012), are substantially modulated during OIS. Consistent with the microscopic 
features of SAHFs described above, they also showed that this loss of TAD 
structure is accompanied by an increased number of long-range chromatin 
interactions representing a spatial clustering of H3K9me3 domains (Chandra et al. 
2015). Interestingly, cells isolated from patients with HGPS also exhibited a loss of 
local connectivity in TADs (Chandra et al. 2015). Since it was reported that HGPS 
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cells are SAHF negative, it appears that the loss of TAD structure and SAHF 
formation are separable events. Indeed, the long-range interactions, representing 
A/B compartments, are drastically lost in late passage HGPS cells (McCord et al. 
2013), and the spatial clustering of H3K9me3 domains observed in OIS cells 
appears to be lacking in HGPS cells (Chandra et al. 2015), further reinforcing a 
modular model where a combination of multiple processes are required for SAHF 
formation (Figure 3). More recently, a Hi-C study of replicatively senescent 
fibroblasts, which also infrequently form SAHFs, was reported: similar to, but less 
intensively than, late passage HGPS cells, replicative senescence illustrated a 
decrease in long-range interactions; however, in contrast to the OIS study 
(Chandra et al. 2015), TADs are relatively conserved and short-range interactions 
are rather increased during replicative senescence (Criscione, De Cecco et al. 
2016). The reason for the difference in Hi-C structure between OIS and replicative 
senescence remains unclear, but these studies raise important questions, such as 
whether the reduction of (a subset of) TADs and modulation of long-range 
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interactions are required for SAHF formation, and how these structural alterations 




Morphological and biochemical analyses have defined multiple levels of 
chromatin structure, from nucleosomes (their modifications and density) to 
macroscopic chromosome structures. Levels of structure between these two 
extremes include chromatin looping, LADs, TADs, and higher order sub-
chromosomal compartments; type A (‘open’) and B (‘closed’) (Gibcus and Dekker 
2013). Researchers have now started to characterize these levels of structure in 
the context of senescence, and found some correlation between (the alterations 
of) them during senescence. These data appear to predict a modular model as 
discussed above; chromatin alterations during senescence involve multiple 
processes that affect different levels of structure, although (in)dependency 
between the levels is not entirely clear. This model may be consistent with the 
heterogeneous nature of the chromatin phenotype in different types of 
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senescence (e.g. SAHF-positive or negative senescence), which might be in part 
due to different efficiency of individual modules. 
 
A number of factors that affect SAHF formation have been identified, as discussed 
above, and it will be necessary to understand which chromatin level or modular 
process these factors regulate during the establishment of senescence. For 
example, it was recently shown that condensin II is required for SAHF formation 
and that ectopic expression of condensin II induces SAHF formation (Yokoyama et 
al. 2015). Condensins, which are essential for mitotic chromosome assembly and 
segregation, play diverse biological roles beyond mitosis, and condensin II in 
particular has been implicated in the spatial organization of chromosomes during 
interphase (Bauer et al. 2012). In addition, condensin II is enriched at the borders 
of TADs, thus it would be interesting to test whether ectopically expressed 
condensin II contributes to senescence-associated chromatin alteration by 
remodeling TAD structure during senescence (Ito and Narita 2015). It will also be 





These analyses will provide further insights into the various levels of chromatin 
and how they affect the quality of senescence, and potentially aging and age-
related disorders.  
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Figure 1. Cellular senescence and organismal aging. Although these processes 
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involve different levels of complexity, evidence linking senescence and aging has 
been accumulating. Correlation between aging and senescence (Aging -> 
Senescence), and some functional relevance of senescence for the aging process 
(Senescence -> Aging) are shown. (?) represents that the statement appears to be 
controversial (see text).  
Figure 2. Heterochromatin assembly through spreading and spatial reorganization. 
A. The primary model of heterochromatin establishment involves ‘spreading’ 
across the linear genome. This has largely been demonstrated in models of early 
development (left). In contrast, recent data suggests that during senescence there 
is a refolding of existing heterochromatin rather than an expansion (right). C. 
Characterization of single SAHF. Chromatin is reorganized into a layered structure 
composing of a core enriched for the histone mark H3K9me3 (red nucleosomes) 
and an outer ring of H3K27me3 (green nucleosomes). Various effectors and 
structural components of SAHF have been identified, including HIRA/ ASF1a, 
JARID1a/b, Cathepsin-L1, HP1 proteins, HMGA proteins, and others. 
Transcriptionally active genes and SADS may loop out from the SAHF core 
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Figure 3: A speculative model of high-order chromatin structure alterations during 
senescence. Recent data suggests a ‘modular’ rearrangement of chromatin during 
senescence – an unwinding of chromatin and a de-condensation of canonical 
heterochromatin, its spatial reorganization and a refolding of chromatin. (a) It is 
unknown how general the features of unwinding are (i.e. loss of LADs, TADs etc.) 
and the extent of these may vary between types of senescence. Here we illustrate 
two possible states following refolding (SAHF –ve and +ve), although a spectrum 
of states is likely. Although we have depicted chromatin as linear in the SAHF –ve 
state, various higher-order structures may exist. 
